| Topic | mean | sd | rank |
| Multiple Sclerosis:
AMPA receptor antagonists as therapy |
6.5 |
1.1 |
5 |
| Temporal Lobe Epilepsy treatment:
Zn++ chelators |
3.6 |
1.1 |
19 |
| Temporal Lobe Epilepsy treatment:
KCQN agonists |
7.2 |
1.5 |
3 |
| Stroke:
PARP |
5.5 |
1.8 |
13 |
| Stroke:
sCR1sLex |
5.2 |
1.0 |
15 |
| CNS neuronal regeneration:
Subacute MS as a tx?? |
8.4 |
0.9 |
1 |
| CNS neuronal regeneration:
BCL2 overexpression as tx |
4.4 |
1.4 |
16 |
| Seizure pharmacotherapy:
Targeted GABA-a subunit pharmacology |
8.0 |
0.7 |
2 |
| Seizure pharmacotherapy:
Are Reactive changes in GABA receptors epileptogenic |
6.1 |
0.7 |
10 |
| Gene therapy in necrotic neurological disease:
Optimism regarding viral vector gene therapy in stroke |
3.9 |
1.7 |
17 |
| Gene therapy in necrotic neurological disease:
XIAP overexpression as tx |
3.8 |
1.7 |
18 |
| Muscular Dystrophy:
a-DB (NOS) |
5.6 |
1.4 |
12 |
| Muscular Dystrophy:
g-SG (non-Dystrophin) |
7.0 |
1.0 |
4 |
| Addiction:
Structure (altered spine density) |
6.4 |
2.0 |
6 |
| Addiction:
Function (altered GLUR2 levels) |
6.0 |
1.0 |
11 |
| Alzheimer's:
Immunization |
6.3 |
1.0 |
7 |
| Alzheimer's:
PSI/gSec/Notch |
5.5 |
1.2 |
14 |
| Parkinson's :
STN lesion to prevent progression |
6.2 |
1.5 |
9 |
| Parkinson's :
GPe lesion to block tremor |
6.3 |
2.2 |
8 |